News Posts List
Bristol's Opdivo boosts kidney cancer survival
09/25/2015
The successful outcome means Opdivo is the first so-called immune checkpoint inhibitor drug to show an improvement in overall survival in patients with renal cell carcinoma (RCC), a common type of kidney cancer.
PATIENTS: Learn About Immuno-Oncology for Kidney Cancer
09/25/2015
News and information about clinical trials and the role of immunotherapy in the treatment of renal cancers.
Metal-based compound to fight kidney cancer
09/25/2015
Researchers have developed a promising titanium and gold based compound that destroys kidney cancer cells, while leaving normal cells unharmed.
WSJ: Price Controls Limit New Drug Development
09/23/2015
Investment—not good intentions—fuels high-risk research, and price controls will limit new therapies.
Switching Therapies in Advanced Renal Cell Carcinoma
09/22/2015
Following progression on first-line therapy, patients with renal cell carcinoma (RCC) often do not need to be hurried to second-line treatment, says David F. McDermott, MD. If there is existing disease that is not harming the patient, and the patient feels well, there is no reason to switch therapies, adds Eric Jonasch, MD.
Penn State's Bob Shoop turns sacks into cash for KCA
09/21/2015
Today's Penn State football news features a look at defensive coordinator Bob Shoop, who announced via Twitter Friday that every sack registered by the Nittany Lions defense will result in a $107 donation to help fight kidney cancer
Request for Proposals: KCA Young Investigator Award
09/19/2015
The Young Investigator Award (YIA) is a one-year research grant totaling $50,000, paid in two equal installments to the awardee’s institution.
Being tall increases the risk of kidney cancer
09/18/2015
Developmental factors in the womb, and during childhood and adolescence, that influence growth are linked to an increased risk...
Healthier lifestyle could cut cancer cases by 84,000
09/18/2015
"The link between tobacco and cancer is widely known and readily accepted by the public but many are not yet fully convinced that healthy eating, regular exercise and not drinking alcohol can lower your cancer risk."
miR‐372 suppresses tumour proliferation
09/08/2015
Up to now, the role of miR‐372 in renal cell carcinoma has remained unknown; in this study, we have aimed to reveal its functional importance in this tumour.
News Feed